MARLBOROUGH, Mass.--(BUSINESS WIRE)--Aug. 29, 2006--Sepracor Inc. (Nasdaq: SEPR) today announced that clinical data for arformoterol tartrate inhalation solution will be presented at the annual conference of the European Respiratory Society, which will be held at the International Congress Center Munich in Munich, Germany, September 2-6, 2006.
